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Abstract
The Synaptic Vesicle Protein 2A (SV2A) is a transmembrane protein whose presence is
reduced both in animal models and in patients with chronic epilepsy. Besides its implication
in the epileptic process, the behavioural consequences of the changes in its expression
remain unclear. The purpose of our research is to better understand the possible role(s) of
this protein through the phenotype of cKO (Grik4 Cre+/-, SV2A lox/lox) mice, male and
female, which present a specific decrease of SV2A expression levels in the hippocampal
glutamatergic neurons but without any epileptic seizures. In this study, we compare the
cKO mice with cHZ (Grik4 Cre+/-, SV2A lox/+) and WT (Grik4 Cre+/+, SV2A lox/lox) mice
through a battery of tests, used to evaluate different features: the anxiety-related features
(Elevated Plus Maze), the locomotor activity (Activity Chambers), the contextual fear-related
memory (Contextual Fear Conditioning), and the spatial memory (Barnes Maze). Our
results showed statistically significant differences in the habituation to a new environment,
an increase in the anxiety levels and spatial memory deficit in the cHZ and cKO groups,
compared to the WT group. No statistically significant differences due to the genotype
appeared in the spontaneous locomotor activity or the fear-linked memory. However, sexual
differences were observed in this last feature. These results highlight not only an important
role of the SV2A protein in the cognitive and anxiety problems typically encountered in epi-
leptic patients, but also a possible role in the symptomatology of other neurodegenerative
diseases, such as the Alzheimer’s disease.
Introduction
The SV2 protein family comprises three integral membrane paralogs: SV2A, SV2B, and SV2C.
In spite of sharing approximately 60% of their sequences, these three isoforms are implicated
in different pathologies, thus suggesting a specific role for each of them [1–4]. Amongst these
isoforms, the most studied is the SV2A protein, due to its ubiquitous expression in the brain
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and its implication in epileptic disease (see hereunder). Beyond the initial suggestion of its role
as a transporter of ions or neurotransmitters [5,6], the SV2A protein seems to act mainly as
modulator of the synaptic transmission. The invalidation of this protein does not alter the
morphology of the brain, the amount of synapses, or their structure [6,7]. However, its absence
reduces the neurotransmission [8,9] and may induce an imbalance between glutamatergic and
GABAergic levels [10–13]. Furthermore, three key findings have identified the SV2A protein
as an all-important molecule involved in the epileptic process. Accordingly, the authors in
[7,14] showed that homozygous SV2A KO mice displayed severe seizures at P7, and died in
status epilepticus two to three weeks after birth. In humans, the homozygous mutation in
SV2A has been also associated with intractable epilepsy, microcephaly, and developmental and
growth retardation [15]. Moreover, SV2A has been proved to be the specific molecular target
of new antiepileptic drugs, such as the levetiracetam [16] or the brivaracetam [17,18].
Different studies have explored the role of the SV2A protein in epilepsy: in humans, several
epileptic disorders are related with a reduction in the amount of SV2A [1,19,20], suggesting a
role of this protein in the epileptogenesis and/or the ictiogenesis [12,13,21]. However, the pos-
sible implication of SV2A in the cognitive impairment and mood disorders accompanying
epileptic disease is still unknown. In light of this, several articles have associated the use of leve-
tiracetam with memory and executive function enhancement [22–24]. As for other patholo-
gies, the use of this antiepileptic drug has highlighted a pro-cognitive effect as well [25–28],
suggesting a role of SV2A in cognition.
The studies carried out with male knockout mice have also provided interesting insights
regarding the role of the SV2A protein in cognition. In particular, the phenotyping of the male
heterozygous SV2A (+/-) mice revealed no motor differences but rather anxiety-like features
in these mice compared with the wild type [29]. Recently, a cKO mouse model (Grik4 Cre+/-,
SV2A lox/lox) has been produced and validated by our laboratory using the Cre/loxP recombi-
nation system [30]. This model is characterized by a decrease of the expression of the SV2A
protein specifically in the glutamatergic pyramidal neurons of the hippocampus, one of the
most affected brain regions in epilepsy [31–34]. Furthermore, this cKO model, in contrast to
the SV2A homozygous or heterozygous mice, does not present an epileptic or pro-epileptic
phenotype (characterized by a lower epileptic threshold, evaluated with the pentylenetetrazol
test) [30], thus increasing their survival and facilitating their evaluation in different tests
[7,14,35].
In this article we evaluate the consequences of the hippocampal downregulation of the
SV2A protein in the phenotype of Grik4 Cre+/-, SV2A lox/lox mice. Using both, males and
females, we studied the possible existence of sex-differences in the cognitive and behavioural
processes evaluated, some of them already reported in epileptic patients [36–38]. Thus, the
main goal of this research is to unravel the possible role of this protein in the cognitive and
behavioural processes associated with the hippocampal structure, offering useful insights into
the role of SV2A, not only in the pathology but also in the healthy brain.
Materials and methods
Animals
Homozygous SV2A conditional knockout mice of both sexes (cKO; Grik4 Cre+/-, SV2A lox/
lox), presenting a decrease of SV2A protein expression in excitatory glutamatergic neurons
of the dentate gyrus and the CA3 hippocampal area, were generated by using the Cre/loxP
recombination system, following the procedure published in [30]. Their phenotype was com-
pared with such of the heterozygous (cHZ; Grik4 Cre+/-, SV2A lox/+) and with the phenotype
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of wild type mice (WT; Grik4 Cre+/+, SV2A lox/lox). All animals were genotyped by PCR fol-
lowing the protocol described in [30].
A total of 141 mice were employed: 66 males and 69 females. Amongst these animals, 27
males and 36 females were also evaluated using the Barnes Maze test to detect spatial learning
or memory problems specifically associated with the hippocampus.
Note that, in principle, for a power of 0.8 and at a critical threshold of 0.05 (alpha), these
sample sizes are able to detect medium to very large effects (ηp
2 > 0.14), but not small effects
which require greater sample sizes [39]. Related calculations were carried out with G�Power
software [40].
Experimental design
Two weeks before starting the experiments, six-week old mice belonging to the three geno-
types were housed in individual standard transparent poly-carbonate cages (31.5 cm (L) × 15.5
cm (W) × 13 cm (H)) with pine sawdust bedding. During all the experimental procedure, the
distance between the cages allowed the animals to maintain visual, olfactory and acoustic inter-
actions. Furthermore, tap water and food (standard pellets, Carfil Quality, Oud-Turnhout, Bel-
gium) were provided ad libitum. The animal room was maintained on a 12:12h dark-light
cycle (lights on at 7:30 am, off at 7:30 pm), at an ambient temperature of 20–24˚C.
When the mice were eight weeks old, the experimental procedure started, performing the
tests during the 12h light cycle (between 9 a.m. and 3 p.m.) (see Fig 1). The first day, the anxi-
ety-related behaviour was evaluated with the Elevated Plus Maze (EPM). From days four to
six, the spontaneous locomotor activity and the habituation to the environment was evaluated
with activity chambers (ACT). The contextual fear conditioning memory was assessed with
the contextual fear conditioning test (CFC), conducted as follows: on day nine (acquisition
trial), mice were placed in the conditioning chamber for the context (conditioned stimulus,
CS)–shock (unconditioned stimulus, US) pairing; then, the contextual fear conditioning mem-
ory was evaluated one hour, one day, and six days later. Finally, the spatial memory was
assessed two weeks later with the Barnes Maze test (BM) using the following method: (1) the
mice were trained during four consecutive days (acquisition trials) to spatially locate a target
hole in the Barnes Maze; (2) the spatial memory of the mice was evaluated the following day
(probe trial); (3) after two weeks, mice were subject to the same 4-day training in order to
assess their memory retention and to determine which level of performance they were able to
reach; (4) the first two days after this last training, the cognitive flexibility of mice was tested in
a reversal learning procedure. At the end of the experimental procedure (second day of rever-
sal learning), animals were sacrificed by cervical dislocation.
Fig 1. Experimental time-line and design. After two weeks of accommodation to the animal laboratory facilities, 69
males and 72 females belonging to the three genotypes (WT, cHZ, and cKO) were evaluated for anxiety-related
behaviour (EPM, d1), spontaneous locomotor activity (ACT, from d4 to d6), and contextual fear conditioning memory
(CFC, from d9 to d15). Following two weeks of recovery, the spatial memory was assessed (BM, from d29 to d55) with
a procedure divided in four parts with a duration of 4 + 1 days, a period of consolidation of two weeks, and 4 + 2 days
respectively. Abbreviations: WT: Grik4 Cre+/+, SV2A lox/lox; cHZ: Grik4 Cre+/-, SV2A lox/+; cKO: Grik4 Cre+/-,
SV2A lox/lox; EPM: Elevated Plus Maze; ACT: Activity chambers; CFC: Contextual fear conditioning; BM: Barnes
Maze.
https://doi.org/10.1371/journal.pone.0217882.g001
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The three parts of the experimental process (testing, scoring, and statistical analysis) were
blinded: animals were identified as members of A, B, or C groups, without information about
the genotype associated to the letters until the generation of results. This course of action elim-
inates intentional or subconscious bias which could interfere in the experimental procedure.
The experimental procedures and protocols used in this investigation were reviewed and
approved by the Institutional Animal Care and Use Committee of the University of Liege (dos-
siers 1258 and 1573), according to the Helsinki declaration, and conducted in accordance with
the European guidelines for care of laboratory animals (2010/63/EU). All efforts were made to
minimise the number of animals used and their suffering. Moreover, the ARRIVE guidelines
(Animal Research Reporting In Vivo Experiments) [41] was followed as closely as possible to
confer a minimal intrinsic quality to the study.
Anxiety-related behaviour: EPM
The EPM was used to evaluate fearfulness/anxiety in mice in a single session. This apparatus
consists of two open and two closed arms (29 cm (L) × 5 cm (W) × 2.5 cm (H) each one)
emerging from a central platform (5 cm × 5 cm) to form a plus shape, which sits 80 cm above
the ground level. The floor and walls of the enclosed arms were made of black hard plastic
(Forex), while the floor of the open arms was made of grey hard plastic (Forex). The behaviour
of the mice was recorded with a webcam (Logitech QuickCam Pro 5000).
For testing, each mouse was placed in the central platform, facing the left open arm, and
was allowed to freely explore the maze during five minutes [42]. After each trial the floor was
wiped clean with Ethanol 70% and dried.
Two parameters were evaluated: (1) the percentage of entries in the open arms with respect
to the total (open / open + closed), and (2) the percentage of time spent in the open arms with
respect to the total testing time (5 minutes). An entry was scored when the mouse had entered
the arm with all four paws. The natural aversion of rodents for open spaces along with the rela-
tionship between anxiogenic drugs and a reduction in the percentage of time spent in the open
arms, make both parameters reliable measures of anxiety in mice [43–45]. Data (see S1 Data)
were analysed with a two-way 3 × 2 ANOVA, considering the Genotype (3 levels) and the Sex
(2 levels) as between-group factors.
Locomotor activity: ACT
The spontaneous locomotor activity and the capacity of habituation to an environment were
evaluated in individual activity chambers (Columbus Instrument, Ohio, USA), for three conse-
cutive sessions (one per day). Each chamber consisted in an enclosure with PVC opaque black
walls and a smooth floor (20.30 cm (L) × 20.30 cm (W) × 20.30 cm (H)) with eight infrared
light-beam sensors 1.54 cm above the chamber floor and spaced 2.54 cm apart. The interrup-
tion of two consecutive sensors in a chamber was detected by a central computer and mea-
sured as a locomotion count by the recording software (Opto-Max Activity Meter, Ohio,
USA).
Mice were placed at the middle of the chamber and allowed to freely explore during one
hour [42,46]. After each individual session, the floor and the walls of the chambers were
cleaned with Ethanol 70% and dried.
The estimation of the travelled distance (in cm) was provided by the recording software
for each 60-minute session. Data (see S2 Data) were assessed with a mixed-model 3 × 2 × 3
ANOVA, incorporating the Genotype and the Sex as between-group factors and the repeated
exposure to the apparatus (Session) as a within-subject factor (3 levels).
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Contextual fear conditioning memory: CFC
The contextual fear conditioning memory was longitudinally assessed at three different time
points to detect possible group differences in memory retention. The apparatus used, an
automated rodent conditioning system (MED Associates Inc., St. Albans, VT, USA, ENV-
307W-TH), consists of two identical conditioning chambers (24 cm (L) × 20 cm (W) × 21.5
cm (H)) each enclosed in a sound-attenuating cubicle with walls and ceiling constructed of
clear Plexiglas. The floor of each chamber consisted of 23 stainless steel rods (3 mm in diame-
ter, 8 mm apart). The chambers were illuminated by a standard single house light, mounted at
the top centre of the right wall. A software program controlled a shock scrambler that delivered
the footshock (US) through the floor rods. Stimuli presentation and data recording from both
boxes were controlled by a MED-PC program via a specific interface.
The procedure followed was inspired by Kimura’s work [47], with a training session and
several sessions to evaluate the CFC memory:
Acquisition trial. The mice were placed in the test chamber (CS), previously cleaned with
70% Ethanol. A lighted up lightbulb indicated the starting of every session, consisting of a pre-
shock period of 5 minutes (basal measure) followed by three moderate footshocks (US) of 2
seconds and an intensity of 0.5 mA, administered every 60 seconds. After the last footshock,
the mice remained in the chamber for another 60 seconds.
CFC evaluation. The mice were exposed to the CS in three different sessions: 1h, 24h and
6 days after the acquisition trial. The exposition consisted in a 5-minute session without any
footshock being delivered.
In all the sessions the parameter analysed was the percentage of freezing time, defining
freezing as the total absence of movements (except those related to breathing). This behaviour
is considered as part of a defensive mechanism relevant to perception and action preparation
in presence of stimulus or situations perceived to be threatening. In humans, there is evidence
that the freezing reaction is also present [48,49]. Data (see S3 Data) were analysed with two
mixed-model 3 × 2 × 4 ANOVA. The first one served us to analyse the acquisition trial, incor-
porating the Genotype and the Sex as between-group factors, and the time pre- (5 minutes)
and post- (1 minute) footshock as a within-subject factor (NumFootshock, 4 levels). With the
second one we analysed the percentage of freezing during the CFC evaluation, using the same
between-group factors than during the acquisition, and the time pre- (5 minutes) and post- (1
minute) footshock as a within-subject factor (NumFootshock: 4 levels).
Spatial memory: BM
We employed the BM (Med Associates, Inc., United Kingdom) to study the spatial memory of
mice. The apparatus consisted of a white, circular table of 122 cm in diameter, elevated 140 cm
above the ground floor, with 18 equally spaced holes of 5 cm in diameter. The aversive stimula-
tion was provided by four LED lights surrounding the maze to produce high-intensity lighting
in the centre of the maze of 1000 lux. A black acrylic box (escape box) (15 cm (L) × 12.5 cm
(W) × 40 cm (H)) was placed under one of the 18 holes (different for each mouse) in order to
provide the mice with protection against the light. A metallic ramp facilitated its access. Three
black spatial cues (circle, triangle, and cross) with dimensions 210 mm (L) x 297 mm (H), were
fixed to the room walls at the BM level (in height), and at 25 cm of the apparatus. A webcam
(Logitech QuickCam Pro 5000) connected to a computer was located over the maze to record
the mouse performance.
For each trial, mice were deposited into a black box (7 cm (L) x 6 cm (W) x 5 cm (H)) cov-
ered with a black cloth and laid in the centre of the maze for 30 seconds. The box was then
lifted, and the mouse was allowed to explore the area to find the escape hole. The trial ended
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when the mouse completely entered on the metallic ramp (the four paws on the ramp). If the
mouse did not enter the escape box within 3 min, it was gently conduced to the target hole.
Once inside the box, the entry was shut and the mouse was kept inside during 1 min before it
was returned to its home cage. The apparatus was cleaned with 70% ethanol after each trial.
The trials were grouped in four phases (acquisition, probe, long-term acquisition, and
reversal learning), following a protocol inspired by Kesby’s work [50,51] and Carrillo-Mora’s
advices about spatial memory evaluation [52] (see S4 Data):
Acquisition trials. Sixteen acquisition trials were performed on four consecutive days
(days 1 to 4), with 4 × 3-minute trials per day and an inter-trial time ranging from 15 to 20
minutes. Data were analysed using a mixed-model 3 × 2 × 4 ANOVA, considering the Geno-
type and the Sex as between-group factors and the Days as a within-subject factor (4 levels).
Probe trial. For the one-day probe trial (day 5), used to assess the spatial memory of mice,
the escape box was removed and the spatial memory of mice was tested during 90 seconds.
Data were analysed with a two-way 3 × 2 ANOVA, with the Genotype and the Sex as between-
group factors. We also employed the nonparametric Chi-Square Test of Association to deter-
minate if there was a relationship between the Genotype and the Strategy (3 levels) employed to
reach the target.
Long-term acquisition trials. Two weeks after the probe test, mice followed an identical
protocol to the acquisition trials (days 19 to 22) to assess the capacity of mice to recover the
spatial learning acquired and to determine which level of performance they were able to
reach. Data were analysed using a mixed-model 3 × 4 ANOVA, considering the Genotype as a
between-group factor (3 levels) and the Days as a within-subject factor (4 levels).
Additionally, the first day (day 19) was considered as a measure of the long-term retention
[53,54], assessed with a two-way 3 × 2 ANOVA, with the Genotype and the Sex as between-
group factors. The escape box was available during all these trials.
Reversal learning. The two consecutive days after the long-term acquisition trials (days
23 and 24), the cognitive flexibility of mice was tested with the reversal learning procedure.
Each day consisted of 4 x 3-min trials identical to the acquisition trials, positioning the escape
box on the opposite side of the table. Data from the last day of long-term acquisition (day 25)
and the two days of reversal learning were analysed with a mixed-model 3 × 2 × 3 ANOVA,
considering the Genotype and the Sex as between-group factors and the Days as a within-sub-
ject factor (3 levels).
Three parameters were measured in all the trials: (1) the latency (time in seconds to enter
the target box), (2) the number of errors (nose pokes and head deflections over any hole that
did not have the target box), and (3) the percentage of use of the spatial strategy (the mouse
only visited the escape hole and/or the two next ones).
During the probe trial we also evaluated the time spent by each mouse in the quadrant of
the maze that contained the target hole, in the centre, and in the rest of the maze. Furthermore,
for each group, we evaluated the preference for the use of three different strategies to find the
target hole: the spatial strategy, the serial strategy (systematic search taking it to consecutive
holes or to every second hole), and the random strategy (the mouse undertakes an unorga-
nized search or searches of separate holes crossing the maze centre).
Data analysis
The statistical analyses were carried out with SPSS (IBM SPSS Statistics 25; USA). GraphPad
Prism 5 (GraphPad Software, Inc.; USA) was used to graphically represent the results.
For the experiments, the Levene’s test was used to evaluate the assumption of homogeneity
of variance. In the experiments including within-subject measures and following a significant
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Mauchly’s test, the Greenhouse–Geisser correction (G.G.) was used to adjust for potential vio-
lations of the assumptions of compound symmetry and sphericity. As we have previously
detailed in the sections pertaining to each of the tests, data were mainly assessed with two-way
ANOVA (EPM; probe trial and long-term retention of BM), mixed-model ANOVA (ACT;
CFC; reversal learning, acquisition and long-term acquisition trials of BM), and the chi-
square test of association (probe trial of BM). The meaningful between-mean differences were
assessed via Tukey’s HSD test (post-hoc) or Bonferroni test derived from the appropriate
mean-square error-term. The critical threshold of statistical significance was always p< .05.
Partial eta squared (ηp
2) are reported as a measure of effect size [39].
Results
Anxiety-related behaviour: EPM
Regarding the percentage of entries, there were no statistically significant differences due to
the Sex (p> .117). However, there was a main effect of the Genotype (ηp2 = 0.085; F2,129 = 5.99,
p = .003), and a significant effect of the interaction Sex × Genotype (ηp2 = 0.047; F2,129 = 3.18,
p = .045). Further pairwise comparisons brought out significant differences between WT and
cHZ groups (p = .007), and WT and cKO groups (p = .014). When the effect of the interaction
Sex × Genotype was analysed in depth, the results highlighted that these differences were signif-
icant only in the group of males (WT vs cHZ: p = .032; WT vs cKO: p = .001), but not in the
group of females (p> .265).
Concerning the percentage of time spent in the open arms, no statistically significant differ-
ences were found due to the variables Sex, the Genotype, or the interaction between both (all
p> .145) (see Fig 2).
Locomotor activity: ACT
The statistical analyses did not reveal any significant differences due to the Genotype, the Sex,
or the interaction Genotype × Sex in the distance travelled, with all p> .598.
However, the variable Session (ηp2 = 0.509; F2,256 = 132.75, p< .001), and the interaction
Genotype × Session (ηp2 = 0.047; F4,256 = 3.13, p = .016) were significant. Further pairwise
comparisons, using the Bonferroni procedure, highlighted differences between the first
session and the rest (p< .001) in all the groups. When we analysed the effect of the interaction
Fig 2. Anxiety-related behaviour: EPM. The bar plots represent the Mean and the SEM of the percentage of entries (A) and the percentage of time
(B) in the open arms during the 5-minute trial. Three groups were compared: WT (Grik4 Cre+/+, SV2A lox/lox, n = 45), cHZ (Grik4 Cre+/-, SV2A
lox/+, n = 47), and cKO (Grik4 Cre+/-, SV2A lox/lox, n = 43), with Males (n = 22) and females (n = 23). (�) and (��) indicates that both, cHZ and cKO
groups are statistically significant to the WT group, as yielded by a Tukey HSD test taken at p< .05 and p< .01, respectively.
https://doi.org/10.1371/journal.pone.0217882.g002
Anxiety and spatial memory problems associated with SV2A expression
PLOS ONE | https://doi.org/10.1371/journal.pone.0217882 June 5, 2019 7 / 20
Genotype × Session, we could observe that the second and the third sessions were only signifi-
cant in the WT group, but not in the cHZ (p> .763) or the cKO group (p> .395). This phe-
nomenon is more clear in the females than in the males. Nevertheless, the interactions
Sex × Session or Genotype × Sex × Session were not significant (all p> .320). Results are repre-
sented in Fig 3.
Contextual fear conditioning memory: CFC
Acquisition trial. During the acquisition trial, no statistically significant differences were
found due to the variables Genotype, the interaction Genotype × NumFootshock or the interac-
tion Genotype × Sex (all p> .442).
Nevertheless, there was a main effect of the Sex (ηp2 = 0.062; F1,130 = 8.56, p = .004), a signif-
icant effect of the repeated administration of footshocks (ηp
2 = 0.526; F2,242 = 144.12, p <
.001), and a significant effect of the interaction Sex × NumFootshock (ηp2 = 0.60; F2,242 = 8.36,
p< .001). Bonferroni’s pairwise comparisons evidenced statistically significant differences in
the percentage of freezing through the acquisition trial, with a significant increase after each
footshock (p< .001). Furthermore, significant differences were found between males and
females after the second and the third footshock, with a higher increase in the time of freezing
in the females compared to the males.
There were no statistically significant differences due to the interaction Genotype × Sex ×
NumFootshock, with p = .95.
CFC evaluation. During the CFC evaluation, the cKO group exhibited a lower percentage
of freezing time than the WT group, in particular 24 hours and 6 days after the training session,
in both sexes. However, the statistical analysis revealed no significant differences due to the
Genotype, the interaction Genotype × Time, or the interaction Genotype × Sex (all p> .586).
Nevertheless, there was a main effect of the Sex (ηp2 = 0.094; F1,130 = 13.39, p< .001), with a
higher percentage of freezing in the group of females. There was also a main effect of the Time
(ηp
2 = 0.044; F3,335 = 5.97, p< .001), with a statistically significant decrease in the percentage
of freezing in the time-points chosen to do the CFC evaluation (p< .001), compared to the
freezing displayed by mice after the last footshock.
The interactions Sex × Time and Genotype × Sex × Time were not significant (all p> .293).
The results of both sessions (acquisition trial and CFC evaluation) are represented in Fig 4.
Fig 3. Locomotor activity: ACT. The lines represent the distance in centimetres travelled by the mice during the 60-minute session (Mean and SEM).
The measure was acquired in three consecutive sessions, comparing the groups WT (Grik4 Cre+/+, SV2A lox/lox), cHZ (Grik4 Cre+/-, SV2A lox/+), and
cKO (Grik4 Cre+/-, SV2A lox/lox). Males (n = 22) are presented in subfigure A, whereas females (n = 23) are shown in subfigure B. (���) indicates that the
corresponding marginal mean (main effect of Session) is significantly different from the other sessions, as yielded by a Bonferroni test taken at p< .001.
Note that in cHZ and cKO groups no statistically significant differences were found between the second and the third sessions (all p> .395).
https://doi.org/10.1371/journal.pone.0217882.g003
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Spatial memory: BM
The results of the different trials (acquisition, long-term acquisition and reversal learning) are
represented together in Fig 5, to better illustrate the continuous learning of mice.
Acquisition trials. There was no significant effect of the variables Genotype, Sex or the
interaction between both in any of the parameters evaluated (number of errors, latency to
reach the target hole or percentage of use of the spatial strategy to reach the target), with all
p> .538.
However, the analyses highlighted statistically significant differences in all the measures
due to the Days, with a significant decrease in the number of errors (ηp2 = 0.096; F2,143 = 6.16,
p = .001) and the latency to reach the target (ηp
2 = 0.138; F2,145 = 9.26, p< .001), and a signifi-
cant increase in the percentage of use of the spatial strategy (ηp
2 = 0.333; F2,136 = 27.41, p<
.001).
There was no significant effect of the interaction Genotype × Days in the number of errors
or in the latency to reach the target (both p> .661), existing a significant difference between
the first and the third days in the three genotypes (all p< .049). However, there was a signifi-
cant effect of the interaction Genotype × Days in the percentage of use of the spatial strategy
(ηp
2 = 0.078; F5,143 = 2.32, p = .047). Further Bonferroni’s pairwise comparisons evidenced sta-
tistically significant differences between the first and the third days in the WT (p = .004) and
in the cKO groups (p> .001), while in the cHZ group these differences did not appeared as
significant until the fourth day of acquisition (p = .002).
The interactions Sex × Days and Genotype × Sex × Days did not appear as significant in any
parameter (all p> .441)
Probe trial. There were no statistically significant differences due to the variables Geno-
type, Sex, or the interaction Genotype × Sex neither in the number of errors, the latency or the
strategy employed to reach the target (p> .109).
However, there was a main effect of the Genotype in the percentage of time spend in the
quadrant where the target was situated, with ηp
2 = 0.108; F2,55 = 3.32, p< .043. Further
Fig 4. Contextual fear conditioning memory: CFC. The bar plots represent the percentage of freezing (Mean and SEM) during each trial, for the
groups WT (Grik4 Cre+/+, SV2A lox/lox), cHZ (Grik4 Cre+/-, SV2A lox/+), and cKO (Grik4 Cre+/-, SV2A lox/lox). Males (n = 22) are presented in
subfigure A, whereas females (n = 23) are shown in subfigure B. Statistically significant differences were found between sex, with p< .001. (���)
indicates that each marginal mean (given by the main effect of the factor shock), is significantly different from the rest, being the last one (shock 3) the
largest, as yielded by Bonferroni tests taken at p< .001. (�) indicates that the marginal mean corresponding to the shock 3 is significantly different
from the marginal means corresponding to the CFC evaluation, as yielded by Bonferroni tests taken at p< .05.
https://doi.org/10.1371/journal.pone.0217882.g004
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Fig 5. Spatial memory: BM. The lines represent the average per day (4 trials) of the three measured parameters: (1) the number of errors
(A, B), (2) the latency to find the target hole (C, D), and (3) the percentage of use of the spatial strategy (E, F) for Males (n = 9) and
Females (n = 12). Three groups were compared (Mean and SEM): WT (Grik4 Cre+/+, SV2A lox/lox), cHZ (Grik4 Cre+/-, SV2A lox/+),
and cKO (Grik4 Cre+/-, SV2A lox/lox). (�) indicates that the corresponding marginal mean (main effect of Day) is significantly different
from the previous ones, as yielded by Bonferroni test taken at p< .05. (#) indicates that the corresponding marginal mean (main effect of
Genotype) is significantly different between the groups WT and cHZ, as yielded by a Tukey HSD test taken at p< .05.
https://doi.org/10.1371/journal.pone.0217882.g005
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Bonferroni’s pairwise comparison evidenced a difference between the WT and cKO groups,
with the latest spending a less percentage of the time during the probe in the quadrant where
the target was situated (p = .034) (see Fig 6E and 6F). Although no statistically significant dif-
ferences were found due to the variable Sex or the interaction Genotype × Sex (both p> .206),
when both sexes were analysed separately the group of females displayed not only significant
differences between the WT and cKO groups (p = .030), but also between the WT and cHZ
groups (p = .017).
Fig 6. Spatial memory: BM probe. The bar plots (Mean and SEM) represent the number of errors (A), the latency to find the target (B)
and the percentage of mice using the spatial, serial, and random strategies (C and D), and the percentage of time spent in different positions
of the maze (quadrant, others, centre) (E and F), for Males (n = 9) and Females (n = 12). Three groups were compared: WT (Grik4 Cre+/+,
SV2A lox/lox), cHZ (Grik4 Cre+/-, SV2A lox/+), and cKO (Grik4 Cre+/-, SV2A lox/lox). (�) indicates that the corresponding marginal
means of both cKO and cHZ groups are significantly different to the WT group (main effect of Genotype), as yielded by a Tukey HSD test
taken at p< .05.
https://doi.org/10.1371/journal.pone.0217882.g006
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Additionally, there were no statistically significant differences in the percentage of time
spent exploring the rest of the holes or in the percentage of time spent in the center of the
maze, neither due to the Genotype, the Sex or the interaction Genotype × Sex (all p> .063).
Long-term retention. The statistical analysis revealed a significant difference due to the
Genotype in the percentage of use of the spatial strategy (ηp2 = 0.141; F2,55 = 4.50, p = .015),
with statistically significant differences between the WT and the cHZ groups (p = .017). This
significant effect of the Genotype was not present in the number of errors or in the latency to
reach the target hole (p< .161). Similarly, there was no significant effect of the Sex or the inter-
action Genotype × Sex in any parameter, with p> .380 in all the cases.
Long-term acquisition trials. The statistical analysis did not show any significant differ-
ences due to the Genotype, the Sex or the interaction between both variables in any of the
parameters evaluated (number of errors, latency to reach the target hole or percentage of use
of the spatial strategy to reach the target), with p> .538.
However, there were statistically significant differences due to the Days in the number of
errors (ηp
2 = 0.068; F2,138 = 4.24, p = .012), and in the use of the spatial strategy (ηp
2 = 0.175;
F3,151 = 11.46, p< .001). Bonferroni’s pairwise comparison highlighted significant differences
in the number of errors between the last two days (p = .030), and in the use of the spatial strat-
egy during the third and the fourth days and the previous ones (both p< .001). There was no
effect of the Days in the latency to reach the target hole (p = .294).
The interactions Genotype × Days and Sex × Days and Genotype × Sex × Days were not sig-
nificant in any of the parameters evaluated, with p > .160 for all.
Reversal learning. The statistical analysis did not reveal any significant differences due to
the Genotype, the Sex or the interaction Genotype × Sex in the number of errors, the latency to
reach the target hole, or the percentage of use of the spatial strategy (all p> .084).
However, there were very large statistically significant differences due to the Days in the
number of errors (ηp
2 = 0.519; F2,110 = 60.38, p< .001), the latency to reach the target hole (ηp
2
= 0.242; F2,95 = 16.60, p< .001), and the use of the spatial strategy (ηp
2 = 0.693; F2,96 = 119.90,
p< .001). In the number of errors and the use of the spatial strategy, these differences were
present between all the days (all p< .001). Nevertheless, there were no differences in the
latency between the last day of long-term acquisition and the last day of reversal learning (p =
.365).
The interactions Genotype × Days, Sex × Days and Genotype × Sex × Days were not signifi-
cant in any of the parameters evaluated, with all p> .196.
Discussion
During the last few years, the SV2A protein has emerged as a possible key element to under-
stand the epileptic disease. Indeed, when the SV2A gene is completely deleted, mice experience
seizures starting seven days after birth and die in status epilepticus around day 15 [7,14]. Fur-
thermore, this protein is the molecular target of one of the most prescribed antiepileptic drugs:
the levetiracetam [16]. Despite the demonstrated relationship between a decrease in SV2A lev-
els in epileptic foci and the presence of brain seizures, the potential implication of this protein
in the cognitive problems exhibited by epileptic patients is barely known. The phenotyping of
Grik4 Cre+/-, SV2A lox/lox (cKO) mice, exempt from spontaneous seizures [30], might there-
fore help us understand the role of this protein in the cognitive process associated with the
hippocampus.
Concerning the spontaneous locomotor activity, our results were similar to those obtained
from the heterozygous SV2A mice (+/-) [29], displaying no significant differences attributable
to the Genotype. Additionally, through the testing procedure, no overt seizure behaviour was
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observed in the cHZ or the cKO groups, which was consistent with the previously published
study regarding these mice [30]. However, cKO and cHZ mice presented a significant different
capacity of habituation to a new environment, compared to the WT group. Indeed, we noticed
an increased behavioural excitability and anxiety in the transgenic mice, reflected in different
adverse reactions to the tests: SV2A cKO mice jumped more frequently out of the Barnes maze
than WT mice, and they tried to avoid the footshocks using the chamber walls and the ceiling.
Moreover, these mice exhibited an increased aggressiveness after being exposed to the contex-
tual fear conditioning test. These emotionally related behaviours have also been reported in
chemoconvulsant-induced epileptic models [55].
Due to the link between the hippocampus and the learning and memory [34,56,57], we
expected the existence of statistically significant differences between the three groups of mice
in the CFC test. Nevertheless, the establishment of a contextual fear conditioning memory was
unaffected by the decrease in the SV2A expression. An initial hypothesis is the interference of
a memory extinction process, which would disrupt the consolidation and maintenance of the
contextual fear conditioning memory. This phenomenon may be caused by a prolonged re-
exposure to the context (CS) without receiving the footshocks (US) [58]. However, we did not
detect any statistically significant decrease in the percentage of freezing through the CFC eval-
uation, disproving this hypothesis. Lamberty et al. [29] obtained equivalent results using the
passive avoidance procedure: heterozygous SV2A (+/-) mice had similar results than wild type
controls at the end of a multi-trial inhibitory avoidance test, even if they have received foot-
shocks along the retention testing. An alternative hypothesis is the existence of compensatory
processes, involving the basolateral amygdala complex: even if there is an important role of the
hippocampus in the association CS-US [34,56], the amygdala is the main locus in the consoli-
dation and maintenance processes of contextual fear memories [59–61]. In this regard, the
cKO mice feature a SV2A decrease only in the hippocampal region, expressing normally
this protein in the rest of the brain structures, including the amygdala. The interconnections
between the amygdaloid complex and the hippocampus, already described by Pitka¨nen’s
group [62,63], could compensate the SV2A decrease in the hippocampus, explaining the
absence of statistically significant differences between groups. A third hypothesis is the possi-
ble existence of a compensation phenomenon: in a review published in 2017 concerning the
role of the SV2 family members [2], it was proposed that the SV2B expression in glutamatergic
neurons could be compensating the SV2A decrease in those neurons, explaining the lack of
other statistically significant differences through the testing process.
Despite the absence of differences due to the Genotype in the CFC test, sex differences were
found in the percentage of freezing time, not only during the acquisition trial, but also during
the CFC evaluation. Several studies have explored the underlying causes of these differences,
reflecting for example that the dorsal hippocampus is more implicated in males, but there is a
preferential recruitment of basal amygdala in the females [64]. Other factors, as the hormones
[65], and a different developmental trajectory in the expression of context-mediated freezing
[66] also play an important role in the sex differences found in the contextual fear.
On the other hand, the results obtained with the EPM and the BM test highlight statistically
significant differences between groups, attributable to the Genotype: in the EPM, cKO and
cHZ groups entered less in the open arms of the EPM, compared with the WT group. This
indicator of anxiety was also found by Lamberty et al. in the heterozygous SV2A mice (+/-)
[29]. Indeed, the existence of anxiety and mood disorders has been reported not only in animal
models of epilepsy [67,68], but also in patients [69–73]. Additionally, it was found a possible
influence of the sex in the anxiety level displayed by the different genotypes (interaction Sex ×
Genotype), with significant group differences in males, but not in females. In the literature, the
sex-specific role of a protein or a neurotransmitter receptor has barely been studied, with only
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a few articles describing sex differences in anxiety due to the CB1 and Glu1 receptors [74,75].
Further studies are required to better understand the implication of SV2A in the sexual differ-
ences observed in anxiety, since it could have an impact in the choice of the treatment, depend-
ing on the sex.
Concerning the BM test, all the genotypes exhibit an equivalent spatial learning through the
acquisition trials. However, during the probe test, the cKO group spent less time in the quad-
rant where the target was located, indicating a possible spatial memory problem associated
with the decrease of SV2A in the hippocampal glutamatergic neurons. In females, also the cHZ
group exhibit a worse performance compared with the WT group. Furthermore, during the
long-term retention trial (day 19), the cHZ group uses the spatial strategy to reach the target
significantly less than the WT group, indicating also in this group possible long-term spatial
memory problems. In this line, problems in visuospatial memory, olfactory discrimination,
and social recognition have also been reported in animal models of epilepsy [55,67,76]. In
these models, the memory impairment is commonly evaluated by means of the Morris water
maze test [55,76,77]. However, in our case, its use would not be recommended since, in this
test, the learning process and the performance are more affected by a high level of anxiety than
in the BM [78,79]. Finally, in clinics it has also been described a comorbidity between epilepsy
and both mild cognitive impaired [80] and dementia [81].
Additionally, the BM selected procedure allowed us to assess the cognitive flexibility of
mice with a two-day reversal learning trials, carried out during the last two days of the proce-
dure. We did not detect statistically significant differences between groups with this comple-
mentary analysis, which suggests that the decrease of the SV2A protein in the hippocampus is
not interfering in the executive function. However, it is necessary to account for the stress suf-
fered by the animals during the previous tests, which might interfere in the reversal learning
evaluation [51]. In conclusion, even if this test can provide us with a first approach to the cog-
nitive flexibility of SV2A cKO mice, more accurate analyses with specific behavioural appara-
tus (e.g. nose-poke portals or a touch-sensitive screen) need to be conducted to specifically
assess the executive function [82].
All these results suggest that, in the hippocampal area, the deletion of the SV2A gene in one
(cHZ mice) or in both alleles (cKO mice) involves statistically significant changes in cognition,
including a cognitive impairment and anxiety-related problems, usually present in the epileptic
disease [83–89]. However, further studies in epileptic patients should be conducted to confirm
the impact of the variations in SV2A protein levels on the severity of the symptomatology.
Conclusions
The phenotyping of Grik4 Cre+/-, SV2A lox/lox mice confirms a link between the decrease of
the SV2A protein in the hippocampus, and the memory and anxiety-related problems detected
in the chronic epilepsy. These results suggest a possible implication of the SV2A protein in
anxiety or memory disorders, such as the post-traumatic stress disorder or the Alzheimer’s
disease.
Supporting information
S1 Data. EPM Data. Raw data acquired with the EPM test. The columns represent the number
and percentage of entries and the time spent (in seconds) in open and closed arms, for the
three groups of mice (WT, cHZ, and cKO). On the right, the descriptive statistics for each
measured variable.
(XLSX)
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S2 Data. ACT Data. Raw data acquired with the ACT test. The columns represent the distance
travelled (cm) by the three groups (WT, cHZ, and cKO), in each of the three 60-minute session
(day1, day2, day3). On the right, the descriptive statistics.
(XLSX)
S3 Data. CFC Data. Raw data acquired with the CFC test. The columns represent the percent-
age of freezing time spent by the three groups (WT, cHZ, and cKO) during the acquisition
trial and the CFC evaluation (1h, 24h and 6 days after the acquisition trial). On the right, the
descriptive statistics.
(XLSX)
S4 Data. BM Data. Raw data acquired with the BM test. The first sheet corresponds to the
acquisition trials (days 1–4), the long-term acquisition trials (days 19–22), and the reversal
learning trials (RL1 and RL2). The columns represent the number of errors (errors), latency
(latence), and the percentage of use of the spatial strategy (perspat) for the three groups of
mice (WT, cHZ, and cKO). The second sheet corresponds to the results obtained during the
probe trial by the three groups of mice. Four variables have been analysed: errors, latency, time
spent in each part of the maze, and strategy. On the right, the descriptive statistics.
(XLSX)
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